Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
156 Leser
Artikel bewerten:
(0)

TEST 17 - Please ignore - Table release on April 16

LONDON, April 16, 2011 /PRNewswire/ -- Curabitur molestie mauris sed dolor dictum iaculis. Nulla sed libero felis [http://www.prnewswire.co.uk ], id viverra urna. Duis dictum, purus in condimentum tincidunt, nisl lacus porta diam, sit amet suscipit libero est sit amet dui. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

- Mauris est velit, iaculis scelerisque tempus semper, eleifend ac erat. - Duis eu mauris ac risus cursus mattis nec ut erat. Donec fringilla dapibus pharetra. Etiam vitae mi quis dolor mattis adipiscing. Etiam metus arcu, ultrices quis dapibus sed, mollis sit amet nulla. - Maecenas vitae nisl tortor, eu pretium nibh. Nullam nisl dui, vulputate at accumsan nec, volutpat eu urna. - Phasellus mi tellus, varius quis adipiscing sed, euismod id quam. - Praesent quam nisi, feugiat vel accumsan ac, fermentum non libero. - Nam aliquam mollis nibh eu placerat.

Curabitur molestie mauris Mauris est velit, iaculis scelerisque (in thousands, except per share amounts) Three Months Ended Six Months Ended (unaudited) (unaudited) June 30, June 30, June 30, June 30, 2010 2009 2010 2009 Continuing operations $'000 $'000 $'000 $'000 Revenues (see note 4) 221,125 195,192 415,305 324,971 Cost of revenues (excl. amortization) (30,323) (23,628) (51,865) (36,417) Amortization of purchased intangibles (14,898) (15,105) (29,432) (20,459) Total cost of revenues (45,221) (38,733) (81,297) (56,876) Gross profit 175,904 156,459 334,008 268,095 Operating expenses: Research and development (27,741) (28,781) (55,523) (48,791) Sales and marketing (50,557) (37,110) (93,457) (65,870) General and administrative (17,264) (15,508) (34,519) (26,796) Other costs Post-acquisition restructuring costs (558) - (558) (846) (Loss) profit on foreign exchange (2,777) (694) 184 (1,127) Total operating expenses (98,897) (82,093) (183,873) (143,430) Profit from operations 77,007 74,366 150,135 124,665 Share of loss of associate (333) (85) (671) (526) Interest receivable 2,178 168 2,985 791 Interest payable (11,372) (2,757) (16,169) (3,261) Profit before income taxes 67,480 71,692 136,280 121,669 Income taxes (15,129) (20,817) (34,215) (36,278) Net profit 52,351 50,875 102,065 85,391 Basic earnings per share $ 0.22 $ 0.21 $ 0.42 $ 0.36 Diluted earnings per share $ 0.21 $ 0.21 $ 0.42 $ 0.36

Curabitur molestie mauris Mauris est velit, iaculis scelerisque Capital Ordinary Share redemption Own Merger Sub shares premium reserve shares reserve -total $'000 $'000 $'000 $'000 $'000 $'000 At January 1, 2010 1,333 1,130,767 135 (845) 27,589 1,158,979 Retained profit - - - - - - Other comprehensive income - - - - - - Stock compensation - - - - - - Share options exercised 6 13,227 - - - 13,233 EBT options exercised - - - 57 - 57 Equity element of convertible loan notes - 97,815 - - - 97,815 Deferred tax on stock options - - - - - - At June 30, 2010 1,339 1,241,809 135 (788) 27,589 1,270,084

Aenean [http://www.google.co.uk/search?hl=en&source=hp&q=prnewswire&aq=0&aqi=g4g-s4g2&aql=&oq=prnews ] ligula leo, dignissim volutpat lacinia vel, consectetur in lorem. In dignissim quam nec leo sagittis tincidunt scelerisque nunc egestas. Donec lobortis interdum magna id congue. Phasellus mattis, turpis ut vulputate faucibus, tortor sapien mollis justo, nec vulputate arcu nibh at dolor. Quisque tempus, quam sed aliquam interdum, lacus sem elementum justo, nec dictum quam ante ac orci. Integer ac nisl eget felis aliquet viverra. Doneclacus enim, fringilla ut elementum in, hendrerit sed odio.

Contact: Morbi diam magna Ultricies quis facilisis et Sagittis@neque.com

PRN Test Company

CONTACT: test

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.